Your browser doesn't support javascript.
loading
Immunotherapy in the treatment of chemoresistant gestational trophoblastic neoplasia - systematic review with a presentation of the first 4 Brazilian cases.
Braga, Antonio; Balthar, Elaine; Souza, Laís Cristhine Santos; Samora, Michelle; Rech, Matheus; Madi, José Mauro; Junior, Joffre Amim; Filho, Jorge Rezende; Elias, Kevin M; Horowitz, Neil S; Sun, Sue Yazaki; Berkowitz, Ross S.
Affiliation
  • Braga A; Rio de Janeiro Trophoblastic Disease Center, Maternidade Escola da Universidade Federal do Rio de Janeiro, RJ, Rio de Janeiro, Brazil; Hospital Universitário Antonio Pedro da Universidade Federal Fluminense, RJ, Niterói, Brazil; Postgraduate Program in Perinatal Health, Faculdade de Medicina, Matern
  • Balthar E; Rio de Janeiro Trophoblastic Disease Center, Maternidade Escola da Universidade Federal do Rio de Janeiro, RJ, Rio de Janeiro, Brazil; Hospital Universitário Antonio Pedro da Universidade Federal Fluminense, RJ, Niterói, Brazil; Postgraduate Program in Perinatal Health, Faculdade de Medicina, Matern
  • Souza LCS; Departament of Obstetrics, Escola Paulista de Medicina, Universidade Federal de São Paulo, SP, São Paulo, Brazil.
  • Samora M; Departament of Obstetrics, Escola Paulista de Medicina, Universidade Federal de São Paulo, SP, São Paulo, Brazil.
  • Rech M; Caxias do Sul Trophoblastic Disease Center, Faculdade de Medicina, Universidade de Caxias do Sul (UCS), RS, Caxias do Sul, Brazil.
  • Madi JM; Caxias do Sul Trophoblastic Disease Center, Faculdade de Medicina, Universidade de Caxias do Sul (UCS), RS, Caxias do Sul, Brazil.
  • Junior JA; Rio de Janeiro Trophoblastic Disease Center, Maternidade Escola da Universidade Federal do Rio de Janeiro, RJ, Rio de Janeiro, Brazil; Hospital Universitário Antonio Pedro da Universidade Federal Fluminense, RJ, Niterói, Brazil; Postgraduate Program in Perinatal Health, Faculdade de Medicina, Matern
  • Filho JR; Rio de Janeiro Trophoblastic Disease Center, Maternidade Escola da Universidade Federal do Rio de Janeiro, RJ, Rio de Janeiro, Brazil; Hospital Universitário Antonio Pedro da Universidade Federal Fluminense, RJ, Niterói, Brazil; Postgraduate Program in Perinatal Health, Faculdade de Medicina, Matern
  • Elias KM; New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Dana Farber Cancer Institute, Harvard Medical School, Boston, USA.
  • Horowitz NS; New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Dana Farber Cancer Institute, Harvard Medical School, Boston, USA.
  • Sun SY; Departament of Obstetrics, Escola Paulista de Medicina, Universidade Federal de São Paulo, SP, São Paulo, Brazil.
  • Berkowitz RS; New England Trophoblastic Disease Center, Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Biology, Brigham and Women's Hospital, Dana Farber Cancer Institute, Harvard Medical School, Boston, USA.
Clinics (Sao Paulo) ; 78: 100260, 2023.
Article in En | MEDLINE | ID: mdl-37523979

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Methotrexate / Gestational Trophoblastic Disease Type of study: Observational_studies / Risk_factors_studies / Systematic_reviews Limits: Female / Humans / Pregnancy Country/Region as subject: America do sul / Brasil Language: En Journal: Clinics (Sao Paulo) Journal subject: MEDICINA Year: 2023 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Methotrexate / Gestational Trophoblastic Disease Type of study: Observational_studies / Risk_factors_studies / Systematic_reviews Limits: Female / Humans / Pregnancy Country/Region as subject: America do sul / Brasil Language: En Journal: Clinics (Sao Paulo) Journal subject: MEDICINA Year: 2023 Document type: Article Country of publication: